Track the 株式会社PRISM BioLab share price and the full insider trade history of the company, a listed issuer based in Japan. Shares are listed on the JP market, under the supervision of EDINET (Japan FSA). Market capitalisation: €6.2bn. The latest transaction was reported on 6 August 2026 (Holding update). Among the most active insiders: WM PARTNERS Co., Ltd.. All data is accessible without an account.
18
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
27Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,037 of 29,063 companies
22.3
score / 100
Value
11
Quality
33
FCF yld-24%
Earn yld-13%
EV/EBITDA·
ROE-38%
Gross mgn40%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
PRISM BioLab es una empresa japonesa que cotiza en el mercado XTKS, especializada en el desarrollo de soluciones biofarmacéuticas. Se enfoca en la innovación en el sector de la biotecnología.